{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:13:03Z","timestamp":1761045183239,"version":"build-2065373602"},"reference-count":72,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T00:00:00Z","timestamp":1325808000000},"content-version":"vor","delay-in-days":704,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>The 3\u2010hydroxy\u20103\u2010methylglutaryl coenzyme A reductase inhibitors (statins) are the second most prescribed therapeutic drug class in the United States after analgesics. Although these agents are used predominantly to reduce cholesterol concentrations in patients with hyperlipidemia, numerous studies have investigated the pleiotropic effects of statins and their potential in the prevention and\/or treatment of other disease states, including cancer. Many theories have been proposed as to how statins may affect the risk or development of malignancies, prompting a clinical review of the literature. Studies have revealed statins to be associated with both increased and decreased cancer risk. Most of the published studies have been observational and retrospective in nature, and most prospective trials evaluated cancer as a secondary end point or adverse event, making it difficult to determine causality. Although most of the available evidence suggests a possible beneficial effect of statins on cancer, further study is needed with better designed trials and\/or increased efforts in evaluating cancer as secondary end points in all statin trials until definite conclusions regarding statin effects on cancer risk and occurrence can be made.<\/jats:p>","DOI":"10.1592\/phco.30.2.177","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T07:58:26Z","timestamp":1264492706000},"page":"177-194","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A Clinical Review of Statins and Cancer: Helpful or Harmful?"],"prefix":"10.1002","volume":"30","author":[{"given":"Michael J.","family":"Gonyeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayton W.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,6]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Centers for Disease Control and Prevention.National health statistics reports. National ambulatory Medicare care survey: 2006 summary. Available fromhttp:www.cdc.govnchsdatanhsrnhsr003.pdf. Accessed November 19 2008."},{"key":"e_1_2_1_3_2","first-page":"933","volume-title":"Goodman & Gilman's the pharmacological basis of therapeutics","author":"Mahley RW","year":"2006"},{"key":"e_1_2_1_4_2","unstructured":"Agency for Healthcare Research and Quality.Statistical brief #205. Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population 2000 and 2005. Available fromhttp:www.meps.ahrq.govmepswebdata_filespublicationsst205stat205.pdf. Accessed November 26 2008."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20758"},{"key":"e_1_2_1_6_2","first-page":"739","article-title":"The role of statins in cancer prevention and treatment","volume":"19","author":"Stamm JA","year":"2005","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.081620098"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02408-9"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(00)00439-3"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.6.1281"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.07.049"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2002.0804216"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39472.580984.AE"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21303"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/89058"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-003-2296-4"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nu.12.070192.002135"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/019262339101900301"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/cbir.1998.0322"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(96)00248-9"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-3-306"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(19981215)71:4<502::AID-JCB5>3.0.CO;2-P"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.14.1062"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307194200"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/156800905774932824"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(03)00299-5"},{"key":"e_1_2_1_27_2","first-page":"229","article-title":"Does statin treatment alter VEGF and HIF expression in human colorectal cancer? An immunohistochemical (IHC) approach: lower gastrointestinal 10328 [abstract]","volume":"93","author":"Four KJS","year":"2006","journal-title":"Br J Surg"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/79510"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/hh2201.100319"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0602.103393"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2004.05.002"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000012168"},{"key":"e_1_2_1_33_2","first-page":"4885","article-title":"Inhibition of epidermal growth factor\u2010induced RhoA translocation and invasion of human pancreatic cancer cells by 3\u2010hydroxy\u20103\u2010methylglutaryl\u2010coenzyme A reductase inhibitors","volume":"61","author":"Kusama T","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/153537020422900701"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgi036"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907083410202"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.15.1748"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2998"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050461"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.19.2437"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.493106"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.20.1615"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-10-199311150-00002"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511163332001"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811053391902"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13638-0"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.24.3215"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043545"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91755-8"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16936-5"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11600-X"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351401"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065994"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.12.011"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000254694.03027.a1"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1507"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.15.2363"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601566"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.027"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm286"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-0931"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000158044.94188.88"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi203"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj499"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj188"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.19.2264"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043792"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk003"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.64"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.053"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.74"},{"journal-title":"The Heart","article-title":"Cancer set to overtake heart disease as top global killer","author":"Nainggolan L","key":"e_1_2_1_73_2"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.30.2.177","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.30.2.177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:29:30Z","timestamp":1761042570000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.30.2.177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1592\/phco.30.2.177"],"URL":"https:\/\/doi.org\/10.1592\/phco.30.2.177","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"2012-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}